Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Who Benefits Most from GLP-1 Agonists
Investor's Business Daily sat down with our CCO, Jayne Hornung, to unpack this phenomenon
It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to help break down sugar and fat, according to Chatham
The surge in demand has led to supply shortages, making it harder for diabetic patientsthose for whom the drugs were originally developedto get their prescriptions filled
Here's What It Could Mean Medically reviewed by Oghenefejiro Okifo | MD , Harvard Medical School | Henry Ford Hospital - Detroit, MI on August 19th, 2025
D., Shamshoum, H., Peppler, W
US$ 24.65
US$ 27.67
US$ 23.94
US$ 25.67
US$ 23.00
US$ 21.35
US$ 22.38
